Personas / Equipo Humano

Manuel Vázquez Carrera

Buscador de publicaciones

Publicaciones

  • Planavila A, Rodríguez-Calvo R, Jové M, Michalik L, Wahli W, Laguna JC and Vazquez M.

    Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.

    CARDIOVASCULAR RESEARCH . 65(4): 832-841. Nº de citas: 156

    [doi:10.1016/j.cardiores.2004.11.011]

  • Planavila A, Laguna JC and Vazquez M.

    Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1687(1-3): 76-83. Nº de citas: 86

    [doi:10.1016/j.bbalip.2004.11.004]

  • Llaverias G, Vazquez M, Sánchez RM, Noé V, Ciudad CJ, Laguna JC and Alegret M.

    Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism.

    JOURNAL OF LIPID RESEARCH . 45(11): 2015-2024. Nº de citas: 60

    [doi:10.1194/jlr.M400049-JLR200]

  • Sanguino E, Roglans N, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Prevention of age-related changes in rat cortex transcription factor activator protein-1 by hypolipidemic drugs.

    BIOCHEMICAL PHARMACOLOGY . 68(7): 1411-1421. Nº de citas: 16

    [doi:10.1016/j.bcp.2004.06.008]

  • Sanguino E, Bejarano R, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Sexual dimorphism in lipid metabolic phenotype associated with old age in Sprague-Dawley rats.

    EXPERIMENTAL GERONTOLOGY . 39(9): 1295-1306. Nº de citas: 18

    [doi:10.1016/j.exger.2004.06.007]

  • Vazquez M and Silvestre JS.

    Insulin analogues in the management of diabetes.

    Methods And Findings In Experimental And Clinical Pharmacology . 26(6): 445-461. Nº de citas: 27

  • Llaverias G, Lacasa D, Viñals M, Vazquez M, Sánchez RM, Laguna JC and Alegret M.

    Reduction of intracellular cholesterol accumulation in THP-1 macrophages by a combination of rosiglitazone and atorvastatin.

    BIOCHEMICAL PHARMACOLOGY . 68(1): 155-163. Nº de citas: 29

    [doi:10.1016/j.bcp.2004.03.009]

  • Llaverias G, Noé V, Peñuelas S, Vazquez M, Sánchez RM, Laguna JC, Ciudad CJ and Alegret M.

    Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages.

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS . 318(1): 265-274. Nº de citas: 67

    [doi:10.1016/j.bbrc.2004.04.021]

  • Roglans N, Vazquez M, Alegret M, Novell F, Zambón D, Ros E, Laguna JC and Sánchez RM.

    Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients.

    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY . 59(12): 855-861. Nº de citas: 54

    [doi:10.1007/s00228-003-0704-1]

  • Planavila A, Jové M, Cabrero A and Vazquez M.

    Modula el metabolismo lipídico del miocardio la hipertrofia cardíaca?

    Nefrologia . 24 Suppl 4: 29-33.